Follow up of Moderate Aortic Regurge After Mitral Valve Replacement
Launched by ASSIUT UNIVERSITY · Jan 10, 2023
Trial Information
Current as of July 25, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying how moderate aortic regurgitation (a condition where the aortic valve doesn't close properly) changes after patients have surgery to replace their mitral valve due to rheumatic heart disease. The main goal is to see if the aortic regurgitation improves or worsens over time after the mitral valve replacement.
To be eligible for this study, patients should have had a mitral valve replacement for rheumatic heart disease and currently have a moderate level of aortic regurgitation. The trial is open to all adults. Participants can expect to have their heart condition monitored closely, helping doctors understand the long-term effects of the surgery. This information could be crucial for improving treatment options for patients with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients underwent mitral valve replacement for rheumatic heart disease and having moderate aortic valve regurge GRADE 2 in assuit university hospitals
- Exclusion Criteria:
- • non rhumatic heart disease ,severe aortic regurge ,moderately severe aortic regurge ,combined ischmic and valvular heart diseaese
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, Assuit, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials